Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | MAP3K14 | Q99558 | 1/20 | 0.32 |
| ▸ | TRIM24 | O15164 | 1/20 | 0.31 |
| ▸ | TRIM33 | Q9UPN9 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2074979 | 1.00 | MAPK1 (0.35) | MAPK1MAP3K14TRIM24TRIM33SMN1; SMN2 | |
| Ethylene SCHEMBL8300809 | 0.92 | MAPK1 (0.32) | MAPK1 | |
| Ethylene SCHEMBL7716211 | 0.92 | MAPK1 (0.32) | MAPK1 | |
| SCHEMBL3295691 | 0.89 | — | — | |
| SCHEMBL7648990 | 0.84 | — | — | |
| SCHEMBL8349202 | 0.84 | — | — | |
| SCHEMBL4515462 | 0.84 | — | — | |
| SCHEMBL1003675 | 0.84 | — | — | |
| SCHEMBL12777784 | 0.84 | — | — | |
| SCHEMBL14290264 | 0.83 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 176 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4280882-A2 | MATERIALS AND METHODS FOR EXTENDING SHELF-LIFE OF FOODS | JP LABORATORIES, INC. (US) | 2023-11-29 | — | — | EP | claimed |
| US-7566710-B2 | Dual molecules containing a peroxide derivative, synthesis and therapeutic applications thereof | Centre National de la Racherche Scientifique (C.N.R.S.) (FR) | 2009-07-28 | — | — | US | claimed |
| EP-1268470-B1 | DUAL MOLECULES CONTAINING A PEROXIDE DERIVATIVE, SYNTHESIS AND THERAPEUTIC APPLICATIONS THEREOF | CENTRE NAT RECH SCIENT (FR) | 2008-02-27 | — | — | EP | claimed |
| US-20050288315-A1 | Dual molecules containing a peroxide derivative, synthesis and therapeutic applications thereof | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (C.N.R.S.) (FR) | 2005-12-29 | — | — | US | claimed |
| US-6949569-B2 | Dual molecules containing a peroxide derivative, synthesis and therapeutic applications thereof | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2005-09-27 | — | — | US | claimed |
| US-20040038957-A1 | Dual molecules containing a peroxide derivative, synthesis and therapeutic applications thereof | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2004-02-26 | — | — | US | claimed |
| EP-0743574-B1 | Migration imaging members | XEROX CORP (US) | 2000-12-27 | — | — | EP | claimed |
| EP-0743573-B1 | Method for obtaining image contrast migration imaging members | XEROX CORP (US) | 2000-09-06 | — | — | EP | claimed |
| EP-0743574-A2 | Migration imaging members | XEROX CORPORATION (US) | 1996-11-20 | — | — | EP | claimed |
| US-5563014-A | SOFTENABLE LAYER CONTAINIG PHOTOSENSITIVE MARKING MATERIAL; TRANSPARENTIZING AGENT | XEROX CORPORATION (US) | 1996-10-08 | — | — | US | claimed |
| EP-0033863-A1 | Process for the production of cis-bicyclo (3.3.0)octane-3,7-dione, and its use | MERCK PATENT GmbH (DE) | 1981-08-19 | — | — | EP | claimed |
| EP-4653428-A1 | PHARMACEUTICALLY ACCEPTABLE SALT AND CRYSTAL FORM OF TRIAZOLE COMPOUND, AND PREPARATION METHOD THEREFOR | Jiangsu Hengrui Pharmaceuticals Co., Ltd. (CN) | 2025-11-26 | — | — | EP | disclosed |
| US-20240317725-A1 | LPA1 SMALL MOLECULE ANTAGONIST | TUOJIE BIOTECH (SHANGHAI) CO., LTD. (CN) | 2024-09-26 | — | — | US | disclosed |
| WO-2024153219-A1 | PHARMACEUTICALLY ACCEPTABLE SALT AND CRYSTAL FORM OF TRIAZOLE COMPOUND, AND PREPARATION METHOD THEREFOR | 江苏恒瑞医药股份有限公司 | 2024-07-25 | — | — | WO | disclosed |
| CN-118359590-A | Triazole compound | 上海拓界生物医药科技有限公司 | 2024-07-19 | — | — | CN | disclosed |
| EP-0270481-A1 | Process for the preparation of optically active carbacyclin intermediates | SCHERING AKTIENGESELLSCHAFT (DE) | 1988-06-08 | — | — | EP | disclosed |
| WO-1988003568-A1 | STEREOSPECIFIC KETO-REDUCTION OF BICYCLOOCTANDIONE-CARBOXYLIC ACID ESTERS BY MICROORGANISMS | SCHERING AKTIENGESELLSCHAFT (DE) | 1988-05-19 | — | — | WO | disclosed |
| WO-1988003526-A1 | NEW PROCESS FOR MANUFACTURING OPTICALLY ACTIVE CARBOCYCLINE INTERMEDIATES | SCHERING AKTIENGESELLSCHAFT (DE) | 1988-05-19 | — | — | WO | disclosed |
| EP-0033863-A1 | Process for the production of cis-bicyclo (3.3.0)octane-3,7-dione, and its use | MERCK PATENT GmbH (DE) | 1981-08-19 | — | — | EP | disclosed |
| EP-0033863-A1 | Process for the production of cis-bicyclo (3.3.0)octane-3,7-dione, and its use | MERCK PATENT GmbH (DE) | 1981-08-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040038957-A1 | Dual molecules containing a peroxide derivative, synthesis and therapeutic applications thereof | DUOX1, DUOX2, CYC1 | MAPK1 955/4885MAP3K14 3533/4885TRIM24 4499/4885 |
| US-20050288315-A1 | Dual molecules containing a peroxide derivative, synthesis and therapeutic applications thereof | DUOX2, DUOX1, QSOX1 | MAPK1 1199/4885MAP3K14 3894/4885TRIM24 4742/4885 |
| US-20240317725-A1 | LPA1 SMALL MOLECULE ANTAGONIST | LPAR1, LPAR2, LPAR4 | MAPK1 197/4885MAP3K14 930/4885TRIM24 3446/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.